Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease

Chronic kidney disease (CKD) was the 12th leading cause of death globally in 2017 with the prevalence of CKD estimated at ~9%. Early detection and intervention for CKD may improve patient outcomes, but standard testing approaches even in developed countries do not facilitate identification of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Claire, Avila-Palencia, Ione, Maxwell, Alexander Peter, Hunter, Ruth F., McKnight, Amy Jayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479694/
https://www.ncbi.nlm.nih.gov/pubmed/37674991
http://dx.doi.org/10.3389/fneph.2022.923068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479694/
https://www.ncbi.nlm.nih.gov/pubmed/37674991
http://dx.doi.org/10.3389/fneph.2022.923068

Ejemplares similares